期刊文献+

不同血液净化方式对慢性肾功能衰竭的疗效分析 被引量:3

Efficacy analysis of different blood purification techniques on chronic renal failure
原文传递
导出
摘要 目的 比较不同血液净化方式对慢性肾功能衰竭(chronic renal failure,CRF)的疗效.方法 选取2005年至2011年期间本院收治的65例需要行血液净化治疗的CRF患者,随机分为3组,其中24例予血液透析联合血液灌流(Hemodialysis and hemoperfusion,HD+ HP)、21例予血液透析(Hemodialysis,HD)、20例予腹膜透析(Peritoneal d(i)alysis,PD),比较3组治疗前后各项临床指标的变化.结果 对比每组治疗前后的血尿素氮(BUN)、血肌酐(Cr)、收缩压(SBP)、舒张压(DBP)、血红蛋白(Hb)、二氧化碳结合力(CO2CP),差异均有统计学意义(P<0.05);对比HD+HP组治疗前后的β2-微球蛋白(β2-MG)差异有统计学意义(P<0.05),HD和PD两组组内对比治疗前后的β2-MG差异均无统计学意义(P>0.05).结论 HD+ HP、HD和PD这三种血液净化方式治疗CRF均能有效改善患者的BUN、Cr、SBP、DBP、Hb、CO2 CP,而且HD+ HP对于β2-MG的清除有着更加显著的效果. Objectives To analyse the efficacy of different blood purification techniques on chronic renal failure(CRF). Methods Totally 65 CRF patients who need to be given blood purification treatment in our hospi tal from 2005 to 2011 were selected and randomly divided into three group,including 24cases in hemodialysis and he moperfusion ( HD + HP) group,21 cases in hemodialysis ( HD ) group and 20cases in peritoneal dialysis ( PD ) group. Compare the change of clinical indicators after the treatment of blood purification. Results Compared with the clinical indicators including BUN, Cr, SBP, DBP, Hb and CO2 CP of each group before and after treatment,there were significant differences ( P 〈 0. 05 ). Moreover, there was significant difference in β2 - MG after treatment in HD + HP group( P 〈0.05) while there were no significant difference in β2 - MG after treatment in HD group and PD group( P 〉 0.05 ). Conclusions HD + HP, HD and PD these three blood purification treatment can effectively improve the clinical indicators of CRF patients, including BUN, Cr, SBP, DBP, Hb and CO2CP. Moreover, HD + HP has a more significant effect on clearing β2 -MG.
出处 《国际泌尿系统杂志》 2013年第6期758-760,共3页 International Journal of Urology and Nephrology
关键词 肾功能衰竭 慢性 净化 Kidney Failure, Chronic Decontamination
  • 相关文献

参考文献9

二级参考文献23

  • 1李岩.中西医结合治疗慢性肾功能不全30例疗效观察[J].云南中医中药杂志,2007,28(7). 被引量:3
  • 2王成,娄探奇,唐骅,陈珠江,石成钢,尹培达,余学清.常用血液净化方法对维持性血液透析患者血清甲状旁腺素的清除效果[J].中华急诊医学杂志,2005,14(1):61-63. 被引量:108
  • 3王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:8262.
  • 4袁宝进 牧素玲.持续不卧床腹膜透析115例临床报道.中华临床医学杂志,2000,9:27-29.
  • 5杨文海.肾脏疾病患者血内中分子物质测定及其临床意义[J].中华肾脏病杂志,1986,(2):241.
  • 6[1]James B.Textbook of medicine W.B Saunders Co. 1985, 554
  • 7Kutner N, Bowles T, Zhang R,et al. Dialysis facility characteristics and variation in employment rates:anational study[J]. Clin J Am Soc Nephrol,2008,3(1) : 111-116.
  • 8Lomonte C,Martino R,Se1vaggiolo M,et al.Ca1citriol pulse therapy and histology of parathyroid glands in hemodialysis patients[J].J Nephrol,2003,16(5):716-720.
  • 9Floege J,Ehlerding G.Beta-2-microglobulin-associated amyloidosis[J].Nephron,1996,72(1):9-26.
  • 10Ku chle C,Fricke H,Held E,et al.High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis[J].Am J Nephrol,1996,16(6):484-488.

共引文献97

同被引文献15

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部